ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases. It focuses on conditions that have limited treatment options, including several forms of inherited blindness such as Leber’s congenital amaurosis, Usher syndrome, and autosomal dominant retinitis pigmentosa.